These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37498094)

  • 21. Dysregulated Expression of Transposable Elements in TDP-43
    Valdebenito-Maturana B; Rojas-Tapia MI; Carrasco M; Tapia JC
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gain-of-function profilin 1 mutations linked to familial amyotrophic lateral sclerosis cause seed-dependent intracellular TDP-43 aggregation.
    Tanaka Y; Nonaka T; Suzuki G; Kametani F; Hasegawa M
    Hum Mol Genet; 2016 Apr; 25(7):1420-33. PubMed ID: 26908597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuronal Expression of UBQLN2
    Picher-Martel V; Renaud L; Bareil C; Julien JP
    Mol Neurobiol; 2019 Jul; 56(7):4680-4696. PubMed ID: 30377984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS.
    Al-Sarraj S; King A; Troakes C; Smith B; Maekawa S; Bodi I; Rogelj B; Al-Chalabi A; Hortobágyi T; Shaw CE
    Acta Neuropathol; 2011 Dec; 122(6):691-702. PubMed ID: 22101323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversible induction of TDP-43 granules in cortical neurons after traumatic injury.
    Wiesner D; Tar L; Linkus B; Chandrasekar A; Olde Heuvel F; Dupuis L; Tsao W; Wong PC; Ludolph A; Roselli F
    Exp Neurol; 2018 Jan; 299(Pt A):15-25. PubMed ID: 28941811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-183-5p regulates TAR DNA-binding protein 43 neurotoxicity via SQSTM1/p62 in amyotrophic lateral sclerosis.
    Kim HC; Zhang Y; King PH; Lu L
    J Neurochem; 2023 Mar; 164(5):643-657. PubMed ID: 36527420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemizygous deletion of Tbk1 worsens neuromuscular junction pathology in TDP-43
    Sieverding K; Ulmer J; Bruno C; Satoh T; Tsao W; Freischmidt A; Akira S; Wong PC; Ludolph AC; Danzer KM; Lobsiger CS; Brenner D; Weishaupt JH
    Exp Neurol; 2021 Jan; 335():113496. PubMed ID: 33038415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutant TDP-43 in motor neurons promotes the onset and progression of ALS in rats.
    Huang C; Tong J; Bi F; Zhou H; Xia XG
    J Clin Invest; 2012 Jan; 122(1):107-18. PubMed ID: 22156203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS.
    Shan X; Vocadlo D; Krieger C
    Neurosci Lett; 2009 Jul; 458(2):70-4. PubMed ID: 19379791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoplasmic Human TDP-43 Mislocalization Induces Widespread Dendritic Spine Loss in Mouse Upper Motor Neurons.
    Dyer MS; Woodhouse A; Blizzard CA
    Brain Sci; 2021 Jun; 11(7):. PubMed ID: 34209287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutant TDP-43 within motor neurons drives disease onset but not progression in amyotrophic lateral sclerosis.
    Ditsworth D; Maldonado M; McAlonis-Downes M; Sun S; Seelman A; Drenner K; Arnold E; Ling SC; Pizzo D; Ravits J; Cleveland DW; Da Cruz S
    Acta Neuropathol; 2017 Jun; 133(6):907-922. PubMed ID: 28357566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice.
    McCann EP; Fifita JA; Grima N; Galper J; Mehta P; Freckleton SE; Zhang KY; Henden L; Hogan AL; Chan Moi Fat S; Wu SS; Jagaraj CJ; Berning BA; Williams KL; Twine NA; Bauer D; Piguet O; Hodges J; Kwok JBJ; Halliday GM; Kiernan MC; Atkin J; Rowe DB; Nicholson GA; Walker AK; Blair IP; Yang S
    J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):162-171. PubMed ID: 31690696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of AMP-activated protein kinase α1 mediates mislocalization of TDP-43 in amyotrophic lateral sclerosis.
    Liu YJ; Ju TC; Chen HM; Jang YS; Lee LM; Lai HL; Tai HC; Fang JM; Lin YL; Tu PH; Chern Y
    Hum Mol Genet; 2015 Feb; 24(3):787-801. PubMed ID: 25256353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proprioceptive sensory neuropathy in mice with a mutation in the cytoplasmic Dynein heavy chain 1 gene.
    Chen XJ; Levedakou EN; Millen KJ; Wollmann RL; Soliven B; Popko B
    J Neurosci; 2007 Dec; 27(52):14515-24. PubMed ID: 18160659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
    Yamashita T; Kwak S
    Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
    Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
    Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in ALS4 mice and human patients.
    Bennett CL; Dastidar SG; Ling SC; Malik B; Ashe T; Wadhwa M; Miller DB; Lee C; Mitchell MB; van Es MA; Grunseich C; Chen Y; Sopher BL; Greensmith L; Cleveland DW; La Spada AR
    Acta Neuropathol; 2018 Sep; 136(3):425-443. PubMed ID: 29725819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
    Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
    Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Motor neuron translatome reveals deregulation of SYNGR4 and PLEKHB1 in mutant TDP-43 amyotrophic lateral sclerosis models.
    Marques RF; Engler JB; Küchler K; Jones RA; Lingner T; Salinas G; Gillingwater TH; Friese MA; Duncan KE
    Hum Mol Genet; 2020 Sep; 29(16):2647-2661. PubMed ID: 32686835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of ALS-associated p.M337V human TDP-43 in mice worsens disease features compared to wild-type human TDP-43 mice.
    Janssens J; Wils H; Kleinberger G; Joris G; Cuijt I; Ceuterick-de Groote C; Van Broeckhoven C; Kumar-Singh S
    Mol Neurobiol; 2013 Aug; 48(1):22-35. PubMed ID: 23475610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.